Global Market Study on Opioids: Market Proliferating on Back of Rising Demand for Pain Management Medication

Global Market Study on Opioids: Market Proliferating on Back of Rising Demand for Pain Management Medication

  • Persistence Market Research
  • March 2021
  • Healthcare
  • 292 pages

Report Description

Global Opioids Market- Scope of Report

A latest publication by Persistence Market Research on the global opioids market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for successful growth of the opioids market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in Persistence Market Research's study. This research study can support readers to know the demand for opioids and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the opioids landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the market. Insights and wisdom presented in this Persistence Market Research study can be leveraged by shareholders in the market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the opioids market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the opioids industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the opioids market offers information divided into four important segments — product, application, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

  • Morphine
  • Codeine
  • Fentanyl
  • Meperidine
  • Methadone

Application

  • Analgesics
  • Cough Suppression
  • Diarrhea Suppression

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Clinics
  • Others

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Key Questions Answered in Report

  • Which geographic regions will continue to remain the most profitable markets for opioids over the coming years?
  • How will changing trends impact the opioids market?
  • How has the COVID-19 crisis impacted market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the opioids market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can businesses in the opioids market avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the opioids market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of opioids market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the opioids market more accurate and reliable.

Have query on this report?

Make an Enquiry

Table of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions

3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Type Innovation / Development Trends

4. Key Success Factors
4.1. Adoption Rate/Usage Analysis- Key Statistics
4.2. Key Regulations, By Region
4.3. PEST Analysis
4.4. Commercial Scope
4.5. Reimbursement Landscape

5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Industry Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising prevalence of chronic diseases and trauma conditions
5.2.2. Unavailability of opioids in Asian and African countries
5.2.3. Increasing product approval
5.2.4. Increasing commercialisation of novel products
5.2.5. Merger & Acquisitions
5.2.6. Regulatory Policies
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue by Product
6.4.2. Revenue by Application
6.4.3. Revenue by End User
6.4.4. Revenue by Country
6.5. 2020 Market Scenario
6.6. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis

8. Global Opioids Market Analysis 2016-2020 and Forecast 2021-2031, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2016-2020
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2021-2031
8.3.1. Morphine
8.3.2. Codeine
8.3.3. Fentanyl
8.3.4. Meperidine
8.3.5. Methadone
8.4.  Market Attractiveness Analysis by Product  

9. Global Opioids Market Analysis 2016-2020 and Forecast 2021-2031, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Application, 2016-2020
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application, 2021-2031
9.3.1. Analgesics
9.3.2. Cough Suppression
9.3.3. Diarrhea Suppression
9.4.  Market Attractiveness Analysis by Application  

10. Market Attractiveness Analysis by Type  Global Opioids Market Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel 
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2016-2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2021-2031
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Diagnostic Imaging Centers
10.3.4. Specialty Clinics
10.3.5. Cancer Research Institutes
10.4.  Market Attractiveness Analysis by Distribution Channel 

11. Global Opioids Market Analysis 2016-2020 and Forecast 2021-2031, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis by Region, 2016- 2020
11.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2021- 2031
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis by Region

12. North America Opioids Market Analysis 2016-2020 and Forecast 2021-2031
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
12.3. Current Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2021-2031
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Application
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis

13. Latin America Opioids Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2019
13.3. Market Size (US$ Mn) Analysis Forecast by Market Taxonomy, 2021-2031
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Application
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis

14. Europe Opioids Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
14.3. Current Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2021-2031
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By Application
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis

15. South Asia Opioids Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
15.3. Current Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By Application
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis

16. East Asia Opioids Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
16.3. Current Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Application
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis

17. Oceania Opioids Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
17.3. Current Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Application
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Opioids Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020
18.3. Current Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By Application
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis

19. Key and Emerging Countries Opioids Market Analysis 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Opioids Market  Value (US$) Analysis, 2020 & 2031
19.2.1. By Product
19.2.2. By Application
19.2.3. By Distribution Channel
19.3. Canada Opioids Market Value (US$) Analysis, 2020 & 2031
19.3.1. By Product
19.3.2. By Application
19.3.3. By Distribution Channel
19.4. Brazil Opioids Market Value (US$) Analysis, 2020 & 2031
19.4.1. By Product
19.4.2. By Application
19.4.3. By Distribution Channel
19.5. Mexico Opioids Market Value (US$) Analysis, 2020 & 2031
19.5.1. By Product
19.5.2. By Application
19.5.3. By Distribution Channel
19.6. Argentina Opioids Market Value (US$) Analysis, 2020 & 2031
19.6.1. By Product
19.6.2. By Application
19.6.3. By Distribution Channel
19.7. Germany Opioids Market Value (US$) Analysis, 2020 & 2031
19.7.1. By Product
19.7.2. By Application
19.7.3. By Distribution Channel
19.8. France Opioids Market Value (US$) Analysis, 2020 & 2031
19.8.1. By Product
19.8.2. By Application
19.8.3. By Distribution Channel
19.9. U.K. Opioids Market Value (US$) Analysis, 2020 & 2031
19.9.1. By Product
19.9.2. By Application
19.9.3. By Distribution Channel
19.10. Spain Opioids Market Value (US$) Analysis, 2020 & 2031
19.10.1. By Product
19.10.2. By Application
19.10.3. By Distribution Channel
19.11. BENELUX Opioids Market Value (US$) Analysis, 2020 & 2031
19.11.1. By Product
19.11.2. By Application
19.11.3. By Distribution Channel
19.12. Russia Opioids Market Value (US$) Analysis, 2020 & 2031
19.12.1. By Product
19.12.2. By Application
19.12.3. By Distribution Channel
19.13. India Opioids Market Value (US$) Analysis, 2020 & 2031
19.13.1. By Product
19.13.2. By Application
19.13.3. By Distribution Channel
19.14. Thailand Opioids Market Value (US$) Analysis, 2020 & 2031
19.14.1. By Product
19.14.2. By Application
19.14.3. By Distribution Channel
19.15. Indonesia Opioids Market Value (US$) Analysis, 2020 & 2031
19.15.1. By Product
19.15.2. By Application
19.15.3. By Distribution Channel
19.16. Malaysia Opioids Market Value (US$) Analysis, 2020 & 2031
19.16.1. By Product
19.16.2. By Application
19.16.3. By Distribution Channel
19.17. China Opioids Market Value (US$) Analysis, 2020 & 2031
19.17.1. By Product
19.17.2. By Application
19.17.3. By Distribution Channel
19.18. Japan Opioids Market Value (US$) Analysis, 2020 & 2031
19.18.1. By Product
19.18.2. By Application
19.18.3. By Distribution Channel
19.19. South Korea Opioids Market Value (US$) Analysis, 2020 & 2031
19.19.1. By Product
19.19.2. By Application
19.19.3. By Distribution Channel
19.20. Australia Opioids Market Value (US$) Analysis, 2020 & 2031
19.20.1. By Product
19.20.2. By Application
19.20.3. By Distribution Channel
19.21. New Zealand Opioids Market Value (US$) Analysis, 2020 & 2031
19.21.1. By Product
19.21.2. By Application
19.21.3. By Distribution Channel
19.22. GCC Countries Opioids Market Value (US$) Analysis, 2020 & 2031
19.22.1. By Product
19.22.2. By Application
19.22.3. By Distribution Channel
19.23. Italy  Opioids Market Value (US$) Analysis, 2020 & 2031
19.23.1. By Product
19.23.2. By Application
19.23.3. By Distribution Channel
19.24. South Africa Opioids Market Value (US$) Analysis, 2020 & 2031
19.24.1. By Product
19.24.2. By Application
19.24.3. By Distribution Channel
19.25. Turkey Opioids Market Value (US$) Analysis, 2020 & 2031
19.25.1. By Product
19.25.2. By Application
19.25.3. By Distribution Channel

20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies 
20.2. Market Share Analysis of Top Players
20.3. Market Concentration

21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive 
21.2.1. Pfizer, Inc.
21.2.1.1. Overview
21.2.1.2. Product Portfolio
21.2.1.3. Profitability by Market Segments (Product/Channel/Region)
21.2.1.4. Sales Footprint
21.2.1.5. Strategy Overview
21.2.2. Boehringer Ingelheim International GmbH
21.2.2.1. Overview
21.2.2.2. Product Portfolio
21.2.2.3. Profitability by Market Segments (Product/Channel/Region)
21.2.2.4. Sales Footprint
21.2.2.5. Strategy Overview
21.2.3. Janssen Pharmaceuticals, Inc.
21.2.3.1. Overview
21.2.3.2. Product Portfolio
21.2.3.3. Profitability by Market Segments (Product/Channel/Region)
21.2.3.4. Sales Footprint
21.2.3.5. Strategy Overview
21.2.4. Sanofi SAIS
21.2.4.1. Overview
21.2.4.2. Product Portfolio
21.2.4.3. Profitability by Market Segments (Product/Channel/Region)
21.2.4.4. Sales Footprint
21.2.4.5. Strategy Overview
21.2.5. Sun Pharmaceutical Industries Ltd.
21.2.5.1. Overview
21.2.5.2. Product Portfolio
21.2.5.3. Profitability by Market Segments (Product/Channel/Region)
21.2.5.4. Sales Footprint
21.2.5.5. Strategy Overview
21.2.6. Actavis Plc. [Teva Pharmaceutical Industries Ltd.]
21.2.6.1. Overview
21.2.6.2. Product Portfolio
21.2.6.3. Profitability by Market Segments (Product/Channel/Region)
21.2.6.4. Sales Footprint
21.2.6.5. Strategy Overview
21.2.7. Mallinckrodt Pharmaceuticals
21.2.7.1. Overview
21.2.7.2. Product Portfolio
21.2.7.3. Profitability by Market Segments (Product/Channel/Region)
21.2.7.4. Sales Footprint
21.2.7.5. Strategy Overview
21.2.8. Endo Pharmaceuticals Inc. [Endo International plc]
21.2.8.1. Overview
21.2.8.2. Product Portfolio
21.2.8.3. Profitability by Market Segments (Product/Channel/Region)
21.2.8.4. Sales Footprint
21.2.8.5. Strategy Overview
21.2.9. Purdue Pharma L.P.
21.2.9.1. Overview
21.2.9.2. Product Portfolio
21.2.9.3. Profitability by Market Segments (Product/Channel/Region)
21.2.9.4. Sales Footprint
21.2.9.5. Strategy Overview
21.2.10. Assertio Therapeutics, Inc. [Assertio Holdings, Inc.]
21.2.10.1. Overview
21.2.10.2. Product Portfolio
21.2.10.3. Profitability by Market Segments (Product/Channel/Region)
21.2.10.4. Sales Footprint
21.2.10.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

List of Table

Table 01: Global Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 
Table 02: Global Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 03: Global Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 04: Global Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Region
Table 05: North America Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 06: North America Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 
Table 07: North America Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 08: North America Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 09: Latin America Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 10: Latin America Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 
Table 11: Latin America Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 12: Latin America Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 13: Europe Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 14: Europe Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 
Table 15: Europe Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 16: Europe Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 17: South Asia Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 18: South Asia Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 
Table 19: South Asia Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 20: South Asia Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 21: East Asia Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 22: East Asia Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 
Table 23: East Asia Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application
Table 24: East Asia Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 25: Oceania Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 26: Oceania Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 
Table 27: Oceania Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application 
Table 28: Oceania Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 29: Middle East and Africa Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 30: Middle East and Africa Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 
Table 31: Middle East and Africa Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application 
Table 32: Middle East and Africa Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product
Table 33: Middle East and Africa Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel

Success Stories

Our Clients